BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fleischman MW, Budoff M, Zeb I, Li D, Foster T. NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis. World J Gastroenterol 2014; 20(17): 4987-4993 [PMID: 24803810 DOI: 10.3748/wjg.v20.i17.4987]
URL: https://www.wjgnet.com/1007-9327/full/v20/i17/4987.htm
Number Citing Articles
1
Monica M. Betancourt-Garcia, Armando Arguelles, Jorge Montes, Ambrosio Hernandez, Manish Singh, R. Armour Forse. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic ChildrenObesity Surgery 2017; 27(1): 236 doi: 10.1007/s11695-016-2440-5
2
Roxana Gutiérrez-Vidal, Blanca Delgado-Coello, Kevin Manuel Méndez-Acevedo, Sandra Calixto-Tlacomulco, Salvador Damián-Zamacona, Jaime Mas-Oliva. Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of AtherosclerosisArchives of Medical Research 2018; 49(7): 456 doi: 10.1016/j.arcmed.2019.01.007
3
Daria L Varganova, Chavdar S Pavlov, Giovanni Casazza, Dimitrinka Nikolova, Christian Gluud. Essential phospholipids for people with non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013301
4
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative ReviewNutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
5
Thomas G. Cotter, Mary Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the DiseaseGastroenterology 2020; 158(7): 1851 doi: 10.1053/j.gastro.2020.01.052
6
Uchenna Agbim, Rotonya M. Carr, Octavia Pickett-Blakely, Sam Dagogo-Jack. Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized ObesityCurrent Obesity Reports 2019; 8(3): 243 doi: 10.1007/s13679-019-00349-x
7
Chaojie Yang, Brian Hallmark, Jin Choul Chai, Timothy D. O’Connor, Lindsay M. Reynolds, Alexis C. Wood, Michael Seeds, Yii-Der Ida Chen, Lyn M. Steffen, Michael Y. Tsai, Robert C. Kaplan, Martha L. Daviglus, Lawrence J. Mandarino, Amanda M. Fretts, Rozenn N. Lemaitre, Dawn K. Coletta, Sarah A. Blomquist, Laurel M. Johnstone, Chandra Tontsch, Qibin Qi, Ingo Ruczinski, Stephen S. Rich, Rasika A. Mathias, Floyd H. Chilton, Ani Manichaikul. Impact of Amerind ancestry and FADS genetic variation on omega-3 deficiency and cardiometabolic traits in Hispanic populationsCommunications Biology 2021; 4(1) doi: 10.1038/s42003-021-02431-4
8
Zobair M. Younossi, Linda Henry, Haley Bush, Alita Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisClinics in Liver Disease 2018; 22(1): 1 doi: 10.1016/j.cld.2017.08.001
9
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
10
Seyed Ali Hosseinian, Jamshid Mehrzad, Seyed Reza Mirhafez, Jafar Saeidi, Rahele Zhiani, Amirhossein Sahebkar. Evaluation of the effect of phytosomal curcuminoids on oxidative stress and inflammatory markers in NAFLD: A randomized double-blind placebo-controlled trialJournal of Functional Foods 2022; 96: 105202 doi: 10.1016/j.jff.2022.105202
11
Manja Zec. Comprehensive Gut Microbiota2022; : 220 doi: 10.1016/B978-0-12-819265-8.00046-2
12
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or ObesityNutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
13
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini ReviewBiomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
14
Eduardo Velasco-Mondragon, Angela Jimenez, Anna G. Palladino-Davis, Dawn Davis, Jose A. Escamilla-Cejudo. Hispanic health in the USA: a scoping review of the literaturePublic Health Reviews 2016; 37(1) doi: 10.1186/s40985-016-0043-2
15
Yutao Zhan, Ping Xie, Dongnian Li, Li Li, Jing Chen, Wei An, Lingqiang Zhang, Chuan Zhang. Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in miceExperimental Cell Research 2017; 355(1): 40 doi: 10.1016/j.yexcr.2017.03.033
16
Sammy Saab, Vignan Manne, Jose Nieto, Jeffrey B. Schwimmer, Naga P. Chalasani. Nonalcoholic Fatty Liver Disease in LatinosClinical Gastroenterology and Hepatology 2016; 14(1): 5 doi: 10.1016/j.cgh.2015.05.001
17
Hai Duc Nguyen, Min-Sun Kim. Effects of chemical mixtures on liver function biomarkers in the Korean adult population: thresholds and molecular mechanisms for non-alcoholic fatty liver disease involvedEnvironmental Science and Pollution Research 2022; 29(52): 78555 doi: 10.1007/s11356-022-21090-4
18
Johanna K. DiStefano, Ignazio S. Piras, Xiumei Wu, Ritin Sharma, Krystine Garcia-Mansfield, Maya Willey, Brooke Lovell, Patrick Pirrotte, Micah L. Olson, Gabriel Q. Shaibi. Changes in proteomic cargo of circulating extracellular vesicles in response to lifestyle intervention in adolescents with hepatic steatosisClinical Nutrition ESPEN 2024; 60: 333 doi: 10.1016/j.clnesp.2024.02.024
19
Rosa Lombardi, Simona Onali, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011640.pub2
20
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos. Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities GloballyJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00082
21
Melissa Lopez-Pentecost, Brian Hallmark, Cynthia A. Thomson, Floyd Chilton, David O. Garcia. Association between Dietary Fatty Acid Intake and Liver Steatosis and Fibrosis in a Sample of Mexican-Origin Hispanic Adults with Overweight or ObesityInternational Journal of Environmental Research and Public Health 2023; 20(4): 3103 doi: 10.3390/ijerph20043103
22
Rosemay A. Remigio-Baker, Matthew A. Allison, Nketi I. Forbang, Rohit Loomba, Cheryl A.M. Anderson, Matthew Budoff, Jeffrey B. Schwimmer, Roger S. Blumenthal, Pamela Ouyang, Michael H. Criqui. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of AtherosclerosisAtherosclerosis 2017; 258: 89 doi: 10.1016/j.atherosclerosis.2016.11.021
23
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United StatesJournal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
24
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
25
Masoumeh Dorosti, Ali Jafary Heidarloo, Farnush Bakhshimoghaddam, Mohammad Alizadeh. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trialBritish Journal of Nutrition 2020; 123(3): 328 doi: 10.1017/S0007114519002769
26
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese. The burden of liver disease in Latin AmericaAnnals of Hepatology 2023; : 101175 doi: 10.1016/j.aohep.2023.101175
27
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD013157.pub2
28
Jennifer K. Frediani, Eric A. Naioti, Miriam B. Vos, Janet Figueroa, Carmen J. Marsit, Jean A. Welsh. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014Environmental Health 2018; 17(1) doi: 10.1186/s12940-017-0350-1
29
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver DiseaseJournal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
30
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamentoPará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
31
Ryan W. Walker, Gillian M. Belbin, Elena P. Sorokin, Tielman Van Vleck, Genevieve L. Wojcik, Arden Moscati, Christopher R. Gignoux, Judy Cho, Noura S. Abul-Husn, Girish Nadkarni, Eimear E. Kenny, Ruth J.F. Loos. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobankJournal of Hepatology 2020; 72(6): 1070 doi: 10.1016/j.jhep.2020.01.029
32
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano. Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver diseaseAnnals of Hepatology 2022; 27(4): 100699 doi: 10.1016/j.aohep.2022.100699
33
Rotonya M. Carr, Amanke Oranu, Vandana Khungar. Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2016; 45(4): 639 doi: 10.1016/j.gtc.2016.07.003
34
Huei-Wen Lim, David E. Bernstein. Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including GeneticsClinics in Liver Disease 2018; 22(1): 39 doi: 10.1016/j.cld.2017.08.008
35
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018Hepatology Communications 2023; 7(1): e0019 doi: 10.1097/HC9.0000000000000019
36
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children StudyThe Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
37
Paulina Vidal‐Cevallos, Aldo Torre, Nahum Mendez‐Sanchez, Misael Uribe, Norberto C. Chavez‐Tapia. Epidemiological and Genetic Aspects of NAFLD and NASH in MexicoClinical Liver Disease 2022; 19(2): 68 doi: 10.1002/cld.1167
38
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman, Peter P. Toth. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationArteriosclerosis, Thrombosis, and Vascular Biology 2022; 42(6) doi: 10.1161/ATV.0000000000000153
39
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewSpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
40
Emir Muzurović, Carol Chiung-Hui Peng, Matthew J. Belanger, Despina Sanoudou, Dimitri P. Mikhailidis, Christos S. Mantzoros. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk FactorsHypertension 2022; 79(7): 1319 doi: 10.1161/HYPERTENSIONAHA.122.17982
41
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
42
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013157
43
Magda Shaheen, Deyu Pan, Katrina M. Schrode, Dulcie Kermah, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia M. Najjar, Theodore C. Friedman. Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other HispanicsHepatology Communications 2021; 5(12): 2068 doi: 10.1002/hep4.1775
44
Paulina Vidal-Cevallos, Ana L. Ordóñez-Vázquez, Omar Procopio-Mosso, Rafael Cardoso-Arias, Misael Uribe, Norberto C. Chávez-Tapia. Cross-sectional pilot study to assess primary healthcare workers’ knowledge of nonalcoholic fatty liver disease in a marginalized community in MexicoScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91199-y
45
Edgar A. Villavicencio, Rebecca M. Crocker, David O. Garcia. A Qualitative Analysis of Mexican-Origin Men’s Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk ReductionAmerican Journal of Men's Health 2021; 15(6): 155798832110633 doi: 10.1177/15579883211063335
46
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
47
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver diseaseAbdominal Radiology 2017; 42(10): 2454 doi: 10.1007/s00261-017-1166-8
48
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013156
49
Maria Luz Fernandez, Sarah A. Blomquist, Brian Hallmark, Floyd H. Chilton. Omega-3 Supplementation and Heart Disease: A Population-Based Diet by Gene Analysis of Clinical Trial OutcomesNutrients 2021; 13(7): 2154 doi: 10.3390/nu13072154
50
Johanna K. DiStefano, Gabriel Q. Shaibi. The relationship between excessive dietary fructose consumption and paediatric fatty liver diseasePediatric Obesity 2021; 16(6) doi: 10.1111/ijpo.12759
51
Marlen Ivon Castellanos-Fernandez, Shreya C. Pal, Marco Arrese, Juan Pablo Arab, Jacob George, Nahum Méndez-Sánchez. Nonalcoholic Fatty Liver Disease in Latin America and AustraliaClinics in Liver Disease 2023; 27(2): 301 doi: 10.1016/j.cld.2023.01.015
52
Mario Jesus Trejo, Kristin E. Morrill, Yann C. Klimentidis, David O. Garcia. Examining genetic associations with hepatic steatosis in Mexican-origin adultsAnnals of Hepatology 2023; 28(5): 101120 doi: 10.1016/j.aohep.2023.101120
53
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni. Genetics Is of the Essence to Face NAFLDBiomedicines 2021; 9(10): 1359 doi: 10.3390/biomedicines9101359
54
Marica Meroni, Miriam Longo, Paola Dongiovanni. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver diseaseExploration of Medicine 2020; 1(4): 218 doi: 10.37349/emed.2020.00015
55
Pegah Golabi, Vasily Isakov, Zobair M. Younossi. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease AwarenessClinics in Liver Disease 2023; 27(2): 173 doi: 10.1016/j.cld.2023.01.001
56
Yueying Qi, Lirong Fan, Decong Ran, Jieda Xu, Yuansong Wang, Jin Wu, Zhongyong Zhang, Muhammad Wasim Khan. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/7764817
57
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
58
Jeff S. Volek, Jonathan Clinthorne, William S. Yancy Jr. Applying a nutrition security lens to the Dietary Guidelines for Americans to address metabolic healthFrontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1141859
59
Julia Kozlitina. Genetic Risk Factors and Disease Modifiers of Nonalcoholic SteatohepatitisGastroenterology Clinics of North America 2020; 49(1): 25 doi: 10.1016/j.gtc.2019.09.001
60
Yvonne Huber, Jörn M. Schattenberg. Nicht-alkoholische Fettlebererkrankung2022; : 1 doi: 10.1007/978-3-662-62484-5_1
61
Reza Ataei Kachouei, Alireza Doagoo, Maral Jalilzadeh, Seyyed Hossein Khatami, Shima Rajaei, Ali Jahanbazi Jahan-Abad, Farzaneh Salmani, Roya Pakrad, Somayeh Mahmoodi Baram, Mitra Nourbakhsh, Mohammad-Amin Abdollahifar, Hojjat Allah Abbaszadeh, Shokoofeh Noori, Mitra Rezaei, Meisam Mahdavi, Mohammad Reza Shahmohammadi, Saeed Karima. Acetyl-11-Keto-Beta-Boswellic Acid Has Therapeutic Benefits for NAFLD Rat Models That Were Given a High Fructose Diet by Ameliorating Hepatic Inflammation and Lipid MetabolismInflammation 2023; 46(5): 1966 doi: 10.1007/s10753-023-01853-y
62
A. Rivera-Andrade, M.F. Kroker-Lobos, M. Lazo, N.D. Freedman, J.W. Smith, O. Torres, K.A. McGlynn, J.D. Groopman, E. Guallar, M. Ramirez-Zea. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based studyNutrition, Metabolism and Cardiovascular Diseases 2019; 29(2): 191 doi: 10.1016/j.numecd.2018.10.008
63
Stanislav Kotlyarov. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2023; 29(4): 597-615 doi: 10.3748/wjg.v29.i4.597
64
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, Yvonne Ayerki Nartey, Elisa Pose, Patrick S. Kamath. Global burden of liver disease: 2023 updateJournal of Hepatology 2023; 79(2): 516 doi: 10.1016/j.jhep.2023.03.017
65
Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018Annals of Hepatology 2024; 29(1): 101154 doi: 10.1016/j.aohep.2023.101154
66
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosisExpert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
67
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
68
Yvonne N. Flores, Aryana T. Amoon, Baolong Su, Rafael Velazquez-Cruz, Paula Ramírez-Palacios, Jorge Salmerón, Berenice Rivera-Paredez, Janet S. Sinsheimer, Aldons J. Lusis, Adriana Huertas-Vazquez, Sammy Saab, Beth A. Glenn, Folasade P. May, Kevin J. Williams, Roshan Bastani, Steven J. Bensinger. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in MexicoLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01526-5
69
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, Edgar A. Villavicencio, Rosa M. Vogel, Melanie L. Bell, Yann C. Klimentidis, David G. Marrero, Cynthia A. Thomson. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin AdultsHepatology Communications 2022; 6(6): 1322 doi: 10.1002/hep4.1896
70
Hai Duc Nguyen, Min-Sun Kim. Cadmium, lead, and mercury mixtures interact with non-alcoholic fatty liver diseasesEnvironmental Pollution 2022; 309: 119780 doi: 10.1016/j.envpol.2022.119780
71
Ethan M. Weinberg, Huy N. Trinh, Roberto J. Firpi, Kalyan Ram Bhamidimarri, Samuel Klein, Jonathan Durlam, Stephanie Watkins, K. Rajender Reddy, Michael Weiss, Richard C. Zink, Anna S. Lok. Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid DiseasesClinical Gastroenterology and Hepatology 2021; 19(5): 996 doi: 10.1016/j.cgh.2020.06.066
72
Pedro Ochoa-Allemant, Jorge A. Marrero, Marina Serper. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United StatesHepatology Communications 2023; 7(12) doi: 10.1097/HC9.0000000000000324
73
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the WorldClinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
74
Stephanie M. Rutledge, Emily R. Soper, Ning Ma, Vikas Pejaver, Scott L. Friedman, Andrea D. Branch, Eimear E. Kenny, Gillian M. Belbin, Noura S. Abul-Husn. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic AncestriesClinical Gastroenterology and Hepatology 2023; 21(10): 2578 doi: 10.1016/j.cgh.2022.12.025
75
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementWorld Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
76
Hadi Emamat, Hossein Farhadnejad, Hossein Poustchi, Azita Hekmatdoost. Galactose intake is related to nonalcoholic fatty liver diseaseNutrition & Food Science 2019; 49(3): 359 doi: 10.1108/NFS-06-2018-0174
77
Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco, Jorge Mateo. A Machine Learning-Based Method for Detecting Liver FibrosisDiagnostics 2023; 13(18): 2952 doi: 10.3390/diagnostics13182952
78
M. H. Le, Y. H. Yeo, R. Cheung, V. W.-S. Wong, M. H. Nguyen. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016Journal of Internal Medicine 2020; 287(6): 711 doi: 10.1111/joim.13035
79
Kristin E. Morrill, Victoria L. Bland, Yann C. Klimentidis, Melanie D. Hingle, Cynthia A. Thomson, David O. Garcia. Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin AdultsInternational Journal of Environmental Research and Public Health 2021; 18(13): 7055 doi: 10.3390/ijerph18137055
80
Huapeng Lin, Xinrong Zhang, Guanlin Li, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00201
81
Lorena S. Pacheco, Ryan D. Bradley, Cheryl A. M. Anderson, Matthew A. Allison. Changes in Biomarkers of Non-Alcoholic Fatty Liver Disease (NAFLD) upon Access to Avocados in Hispanic/Latino Adults: Secondary Data Analysis of a Cluster Randomized Controlled TrialNutrients 2022; 14(13): 2744 doi: 10.3390/nu14132744
82
Ankit P. Laddha, Lindsey Dzielak, Cedric Lewis, Raymond Xue, José E. Manautou. Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic reviewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(3): 167037 doi: 10.1016/j.bbadis.2024.167037
83
Mariana Lazo, Usama Bilal, Rafael Perez-Escamilla. Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic OriginCurrent Diabetes Reports 2015; 15(12) doi: 10.1007/s11892-015-0674-6
84
Paulo S. Pinheiro, Heidy N. Medina, Karen E. Callahan, Patricia D. Jones, Clyde P. Brown, Sean F. Altekruse, Katherine A. McGlynn, Erin N. Kobetz. The association between etiology of hepatocellular carcinoma and race‐ethnicity in FloridaLiver International 2020; 40(5): 1201 doi: 10.1111/liv.14409
85
Meng-Yuan Wu, Jian-Gao Fan. Gut microbiome and nonalcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2023; 22(5): 444 doi: 10.1016/j.hbpd.2023.06.006
86
Kurinchi Selvan Gurusamy, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews2015;  doi: 10.1002/14651858.CD011640
87
Zahra Sadeghianpour, Bahman Cheraghian, Hamid Reza Farshchi, Mohsen Asadi-Lari. Non-alcoholic fatty liver disease and socioeconomic determinants in an Iranian cohort studyBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02964-4
88
Yutao Zhan, Fei Zhao, Ping Xie, Leping Zhong, Dongnian Li, Qujing Gai, Li Li, Hongshan Wei, Lingqiang Zhang, Wei An. Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liverLipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0040-3
89
Hadi Emamat, Hamid Ghalandari, Ali Saneei Totmaj, Hadith Tangestani, Azita Hekmatdoost. Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control studyBMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00721-w